Rich Aldrich - Profile and Investment Details

Investor Profile

Rich Aldrich is a Venture Capital, Founder, Investor, Private Equity Firm based in Key Biscayne, Florida, United States with a diverse investment portfolio that includes companies such as Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology, Alnara Pharmaceuticals, Colorescience, Calithera Biosciences, Bicycle Therapeutics, PTC Therapeutics, Flex Pharma, ArcherDX, Sitryx Therapeutics, KalVista Pharmaceuticals, ImmuneID, XyloCor Therapeutics, Werewolf Therapeutics, Renovia, Grail, Axial Biotherapeutics, Channel Medsystems, IlluminOss Medical, Millendo Therapeutics, Be Biopharma, Twentyeight-Seven Therapeutics, Recros Medica, TScan Therapeutics, Pyxis Oncology. Over time, Rich Aldrich has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rich Aldrich is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Medical Testing, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Health Diagnostics, Medical, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Rich Aldrich, as their portfolio suggests a familiarity and interest in this area.

Understanding Rich Aldrich’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.